AHCY and hepatocellular carcinoma: Complete loss of AHCY leads to embryonic lethality (Dickinson et al., 2016), whereas AHCY deficiency in humans results in a number of pathological consequences including neurodevelopmental disorders, myopathy, hepatocellular carcinoma, and early childhood death (Barić, 2009; Stender et al., 2015).